It is therefore apparent that development of fibrosis or cancer-associated invasiveness is actively promoted by TGF-β signalling, which involves multiple cross talking pathways, usually aiming at the regulation of ECM expression and remodelling. The gene discussed is TGFB1; the disease is cancer.